Abigail Meyers
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Abigail Meyers has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Bahar Bassiri Gharb
Department of Plastic Surgery Cleveland Clinic Cleveland Ohio USA
8 shared publications - Payam Sadeghi
University Hospitals Cleveland Medical Center, Cleveland, OH 44106, USA
8 shared publications - Diane Jo
Department of Plastic Surgery, Cleveland Clinic, Cleveland, OH, USA
7 shared publications - Ryan Khalaf
Department of Plastic Surgery, Cleveland Clinic, Cleveland, OH, USA
7 shared publications - Antonio Rampazzo
Cleveland Clinic, Cleveland, OH, USA
6 shared publications - Francis Papay
BrainXAI Research, BrainX,LLC., Cleveland, OH, USA
5 shared publications
Latest Publications
- Open Access
- 17 February 2025
- Published by Wiley in Artificial Organs
- Vol. 49 (6) , 955-966
Ex Vivo Preservation of Porcine Vascularized Composite Soft Tissue Allografts
Introduction: The aim of this study was to evaluate ex vivo perfusion (EVP) for vascularized composite tissue preservation. We hypothesized that EVP could maintain allografts in near‐physiologic conditions for ≥ 24 h. Methods: Twenty superior epigastric artery perforator‐based abdominal flaps were procured from 10 Yorkshire pigs. Flaps were preserved for 12 h ( n = 5) or 24 h ( n = 5) using EVP with an oxygenated colloid solution containing HBOC‐201 oxygen carrier (HbO 2 Therapeutics, Souderton, PA). Contralateral flaps were cold storage controls (4°C) ( n = 10). Hemodynamics, temperature, gases, metabolites, electrolytes, indocyanine green (ICG) angiography, and weight were analyzed. Biopsies were taken every 6 h for histology. Results: Ischemia time was 16 ± 6 min. There were no significant differences between the 12 h EVP and 24 h EVP groups at perfusion end for the following parameters: MAP ( p = 0.63), pH ( p = 0.77), pO2 ( p = 0.20), venous pCO 2 ( p = 0.22), lactate ( p = 0.28), creatine kinase ( p = 0.89), or myoglobin ( p = 0.95). Electrolytes were also comparable at perfusion termination: sodium ( p = 0.31), potassium ( p = 0.61), and calcium ( p = 0.29). After 12 h, flaps in the 24 h EVP group demonstrated a significant weight decrease (−4.5% [−4.6%, −4.1%] weight change), compared to the 12 h EVP group (1.2% [−1.1%, 1.6%] weight change) ( p = 0.03). At perfusion end, weight did not differ from baseline between the 24 h EVP (2.3% [0%, 3%]) and 12 h EVP groups ( p = 0.37). SCS flap weight was unchanged from baseline at 12 h ( p = 0.954) and 24 h ( p = 0.616). ICG revealed well‐perfused flaps. H&E staining revealed preserved skin architecture without histopathological changes. Conclusion: EVP preserved flaps for 24 h within physiologic parameters and without development of edema. EVP may extend preservation time for VCAs.
- 17 February 2025
- Published by Wiley in Artificial Organs
- Vol. 49 (6) , 955-966
Open AccessEx Vivo Preservation of Porcine Vascularized Composite Soft Tissue Allografts
Introduction: The aim of this study was to evaluate ex vivo perfusion (EVP) for vascularized composite tissue preservation. We hypothesized that EVP could maintain allografts in near‐physiologic conditions for ≥ 24 h. Methods: Twenty superior epigastric artery perforator‐based abdominal flaps were procured from 10 Yorkshire pigs. Flaps were preserved for 12 h ( n = 5) or 24 h ( n = 5) using EVP with an oxygenated colloid solution containing HBOC‐201 oxygen carrier (HbO 2 Therapeutics, Souderton, PA). Contralateral flaps were cold storage controls (4°C) ( n = 10). Hemodynamics, temperature, gases, metabolites, electrolytes, indocyanine green (ICG) angiography, and weight were analyzed. Biopsies were taken every 6 h for histology. Results: Ischemia time was 16 ± 6 min. There were no significant differences between the 12 h EVP and 24 h EVP groups at perfusion end for the following parameters: MAP ( p = 0.63), pH ( p = 0.77), pO2 ( p = 0.20), venous pCO 2 ( p = 0.22), lactate ( p = 0.28), creatine kinase ( p = 0.89), or myoglobin ( p = 0.95). Electrolytes were also comparable at perfusion termination: sodium ( p = 0.31), potassium ( p = 0.61), and calcium ( p = 0.29). After 12 h, flaps in the 24 h EVP group demonstrated a significant weight decrease (−4.5% [−4.6%, −4.1%] weight change), compared to the 12 h EVP group (1.2% [−1.1%, 1.6%] weight change) ( p = 0.03). At perfusion end, weight did not differ from baseline between the 24 h EVP (2.3% [0%, 3%]) and 12 h EVP groups ( p = 0.37). SCS flap weight was unchanged from baseline at 12 h ( p = 0.954) and 24 h ( p = 0.616). ICG revealed well‐perfused flaps. H&E staining revealed preserved skin architecture without histopathological changes. Conclusion: EVP preserved flaps for 24 h within physiologic parameters and without development of edema. EVP may extend preservation time for VCAs.
- 15 September 2023
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 86, 195-196
Response to: Impact of virtual plastic surgery health encounters in facilitating access to care and reducing healthcare disparities
- 15 September 2023
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 86, 195-196
Response to: Impact of virtual plastic surgery health encounters in facilitating access to care and reducing healthcare disparities
- 15 September 2023
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 86, 197-198
Response to: Impact of telemedicine on medical student training
- 15 September 2023
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 86, 197-198
Response to: Impact of telemedicine on medical student training
- 8 July 2023
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 85, 299-308
Efficacy of virtual plastic surgery encounters in establishment of care and surgical conversion
- 8 July 2023
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 85, 299-308
Efficacy of virtual plastic surgery encounters in establishment of care and surgical conversion
- Open Access
- 19 May 2023
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery - Global Open
- Vol. 11 (5S) , 78
124. Porcine Model for Superior Epigastric Artery Based Perforator Flap in Reconstructive Microsurgery
- 19 May 2023
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery - Global Open
- Vol. 11 (5S) , 78
Open Access124. Porcine Model for Superior Epigastric Artery Based Perforator Flap in Reconstructive Microsurgery
- Open Access
- 19 May 2023
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery - Global Open
- Vol. 11 (5S) , 88-89
140. Efficacy of Virtual Plastic Surgery Encounters in Establishment of Care and Surgical Conversion
- 19 May 2023
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery - Global Open
- Vol. 11 (5S) , 88-89
Open Access140. Efficacy of Virtual Plastic Surgery Encounters in Establishment of Care and Surgical Conversion
- Open Access
- 26 April 2023
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery - Global Open
- Vol. 11 (4S) , 107
D93. Efficacy of Virtual Plastic Surgery Encounters in Establishment of Care and Surgical Conversion
- 26 April 2023
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery - Global Open
- Vol. 11 (4S) , 107
Open AccessD93. Efficacy of Virtual Plastic Surgery Encounters in Establishment of Care and Surgical Conversion
- Open Access
- 15 November 2022
- Published by Wiley in Artificial Organs
- Vol. 47 (2) , 290-301
Weight gain is an early indicator of injury in ex vivo normothermic limb perfusion (EVNLP)
Purpose: There are no established criteria for discontinuing ex vivo normothermic limb perfusion (EVNLP) before irreversible damage occurs. This study evaluates weight gain as an indicator of injury during EVNLP.Methods: Sixteen Yorkshire pig forelimbs were procured and preserved using EVNLP with a hemoglobin‐based oxygen carrier (HBOC‐201) or static cold storage. EVNLP continued until termination criteria were met: arterial pressure ≥ 115 mm Hg, compartment pressure > 30 mm Hg, or 20% reduction of oxygen saturation. Limb weight, contractility, hemodynamics, perfusate electrolytes, metabolites and gases were recorded. Muscles were biopsied 6‐h, and muscle injury scores (MIS) calculated. Forearm compartment pressures and indocyanine green (ICG) angiography were recorded at endpoint. Outcomes were compared at 2%, 5%, 10%, and 20% limb weight gain.Results: EVNLP lasted 20 ± 3 h. Weight gain was observed after 13 ± 5 h (2%), 15 ± 6 h (5%), 16 ± 6 h (10%), and 19 ± 4 h (20%). Weight correlated positively with MIS (ρ = 0.92, p < 0.0001), potassium (ρ = −1.00, p < 0.0001), pressure (ρ = 0.78, p < 0.0001), and negatively with contractility (ρ = −0.96, p = 0.011). At 5% weight gain, MIS (p < 0.0001), potassium (p = 0.03), and lactate (p < 0.0001) were significantly higher than baseline. Median muscle contractility was 5 [3–5] at 2% weight gain, 4 [1–5] at 5%, 3 [0–4] and 2 [0–2] at 10% and 20%, respectively. At 20% weight gain, contractility was significantly lower than baseline (p = 0.003). Percent weight gain correlated negatively with endpoint ICG hoof fluorescence (r = −0.712, p = 0.047).Conclusions: Weight gain correlated with microscopic muscle injury and was the earliest evidence of limb dysfunction. Weight gain may serve as a criterion for discontinuation of EVNLP.
- 15 November 2022
- Published by Wiley in Artificial Organs
- Vol. 47 (2) , 290-301
Open AccessWeight gain is an early indicator of injury in ex vivo normothermic limb perfusion (EVNLP)
Purpose: There are no established criteria for discontinuing ex vivo normothermic limb perfusion (EVNLP) before irreversible damage occurs. This study evaluates weight gain as an indicator of injury during EVNLP.Methods: Sixteen Yorkshire pig forelimbs were procured and preserved using EVNLP with a hemoglobin‐based oxygen carrier (HBOC‐201) or static cold storage. EVNLP continued until termination criteria were met: arterial pressure ≥ 115 mm Hg, compartment pressure > 30 mm Hg, or 20% reduction of oxygen saturation. Limb weight, contractility, hemodynamics, perfusate electrolytes, metabolites and gases were recorded. Muscles were biopsied 6‐h, and muscle injury scores (MIS) calculated. Forearm compartment pressures and indocyanine green (ICG) angiography were recorded at endpoint. Outcomes were compared at 2%, 5%, 10%, and 20% limb weight gain.Results: EVNLP lasted 20 ± 3 h. Weight gain was observed after 13 ± 5 h (2%), 15 ± 6 h (5%), 16 ± 6 h (10%), and 19 ± 4 h (20%). Weight correlated positively with MIS (ρ = 0.92, p < 0.0001), potassium (ρ = −1.00, p < 0.0001), pressure (ρ = 0.78, p < 0.0001), and negatively with contractility (ρ = −0.96, p = 0.011). At 5% weight gain, MIS (p < 0.0001), potassium (p = 0.03), and lactate (p < 0.0001) were significantly higher than baseline. Median muscle contractility was 5 [3–5] at 2% weight gain, 4 [1–5] at 5%, 3 [0–4] and 2 [0–2] at 10% and 20%, respectively. At 20% weight gain, contractility was significantly lower than baseline (p = 0.003). Percent weight gain correlated negatively with endpoint ICG hoof fluorescence (r = −0.712, p = 0.047).Conclusions: Weight gain correlated with microscopic muscle injury and was the earliest evidence of limb dysfunction. Weight gain may serve as a criterion for discontinuation of EVNLP.